48,868
edits
(→See also: +C1q nephropathy) |
|||
Line 166: | Line 166: | ||
===EM=== | ===EM=== | ||
*Diffuse subepithelial deposits - spike forming. | *Diffuse subepithelial deposits - spike forming. | ||
==C1q nephropathy== | |||
===General=== | |||
*Nephrotic syndrome. | |||
*Controversial entity - may be a variant of FSGS.<ref name=pmid12969141>{{Cite journal | last1 = Markowitz | first1 = GS. | last2 = Schwimmer | first2 = JA. | last3 = Stokes | first3 = MB. | last4 = Nasr | first4 = S. | last5 = Seigle | first5 = RL. | last6 = Valeri | first6 = AM. | last7 = D'Agati | first7 = VD. | title = C1q nephropathy: a variant of focal segmental glomerulosclerosis. | journal = Kidney Int | volume = 64 | issue = 4 | pages = 1232-40 | month = Oct | year = 2003 | doi = 10.1046/j.1523-1755.2003.00218.x | PMID = 12969141 }}</ref> | |||
*Steroid resistant - like FSGS.<ref name=pmid3875286>{{Cite journal | last1 = Jennette | first1 = JC. | last2 = Hipp | first2 = CG. | title = C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. | journal = Am J Kidney Dis | volume = 6 | issue = 2 | pages = 103-10 | month = Aug | year = 1985 | doi = | PMID = 3875286 }}</ref> | |||
===Microscopic=== | |||
Features: | |||
*[[Focal segmental glomerulosclerosis]]. | |||
===IF=== | |||
*C1q +ve. | |||
=See also= | =See also= |
edits